The Hyper IgM Podcast

The Hyper IgM Podcast

Ezra Fineman

In the world of rare diseases, amplifying patient voices is crucial for empowering others to make informed treatment decisions and for providing insights to healthcare professionals and researchers about the patient experience and its impact on quality of life. With conditions like Hyper IgM Syndrome, a rare immune deficiency affecting one in a million individuals, the majority of those affected are children. Yet, narratives in the pediatric rare disease realm often stem from the perspectives of parents, medical professionals, or adult survivors.

Breaking this mold, the Hyper IgM Foundation has launched an innovative podcast, where children affected by X-Linked Hyper IgM Syndrome share their own stories. Led by Ezra Fineman, a 15-year-old high school freshman and two-time recipient of a hematopoietic stem cell transplant due to Hyper IgM Syndrome, this podcast offers a fresh format. Here, young patients interview one another, providing intimate and informative conversations about their experiences with Hyper IgM Syndrome and life with a rare disease. This approach offers a unique glimpse into the patient journey from the perspective of pediatric patients themselves.

Where can you listen?

Apple Podcasts Logo Spotify Logo Podtail Logo Google Podcasts Logo RSS

Episodes

Questions & Answers

How many episodes are there of The Hyper IgM Podcast?

There are 3 episodes avaiable of The Hyper IgM Podcast.

What is The Hyper IgM Podcast about?

We have categorized The Hyper IgM Podcast as:

  • Business
  • Health & Fitness
  • Non-Profit
  • Medicine

Where can you listen to The Hyper IgM Podcast?

The Hyper IgM Podcast is available, among others places, on:

  • Spotify
  • Apple Podcasts
  • Podtail
  • Google Podcasts

When did The Hyper IgM Podcast start?

The first episode of The Hyper IgM Podcast that we have available was released 11 April 2024.

Who creates the podcast The Hyper IgM Podcast?

The Hyper IgM Podcast is produced and created by Ezra Fineman.